| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药主营业务(元) | 6,411,516,229.06 | 11,440,239,653.78 | - | 10,505,802,935.74 | 4,956,591,096.01 |
| 医药(元) | - | - | 5,917,926,806.82 | - | - |
| 营业成本(元) | |||||
| 医药主营业务(元) | 4,826,838,444.09 | 8,511,511,467.38 | - | 7,996,356,507.92 | 3,713,512,108.93 |
| 医药(元) | - | - | 4,340,070,263.76 | - | - |
| 毛利(元) | |||||
| 医药主营业务(元) | 1,584,677,784.97 | 2,928,728,186.40 | - | 2,509,446,427.82 | 1,243,078,987.08 |
| 医药(元) | - | - | 1,577,856,543.06 | - | - |
| 毛利率(%) | |||||
| 医药主营业务(%) | 24.72 | 25.60 | - | 23.89 | 25.08 |
| 医药(%) | - | - | 26.66 | - | - |
| 收入构成(%) | |||||
| 医药主营业务(%) | 100.00 | 100.00 | - | 100.00 | 100.00 |
| 医药(%) | - | - | 100.00 | - | - |
| 毛利构成(%) | |||||
| 医药主营业务(%) | 100.00 | 100.00 | - | 100.00 | 100.00 |
| 医药(%) | - | - | 100.00 | - | - |